DMCC SPECIALITY CHEMICALS (DMCC)₹242.15−0.49%Specialty Chemicals
In the Sep 2026 quarter (consolidated), DMCC SPECIALITY CHEMICALS reported sales of ₹274 Cr, up 116.8% from Sep 2025, and net profit of ₹3.22 Cr, down 43.8% year on year. For the year to Mar 2026, sales were ₹583 Cr and net profit ₹26.87 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 80.72 | 84.10 | 85.47 | 103 | 118 | 125 | 127 | 126 | 151 | 178 | 254 | 274 |
| Expenses | 73.70 | 76.79 | 76.70 | 87.65 | 101 | 110 | 111 | 112 | 137 | 161 | 220 | 263 |
| Operating Profit | 7.07 | 7.38 | 8.82 | 15.28 | 17.69 | 15.08 | 16.83 | 13.97 | 14.67 | 17.66 | 34.05 | 11.38 |
| OPM % | 8.8% | 8.8% | 10.3% | 14.9% | 15.0% | 12.0% | 13.3% | 11.1% | 9.7% | 9.9% | 13.5% | 4.2% |
| Other Income | 0.71 | 9.28 | 0.20 | 0.30 | 0.38 | 0.43 | 0.36 | 0.29 | 0.18 | 0.15 | 0.29 | 0.20 |
| Interest | 3.57 | 3.87 | 3.02 | 2.78 | 2.54 | 2.20 | 2.04 | 1.92 | 2.32 | 3.38 | 3.50 | 3.84 |
| Depreciation | 3.93 | 4.35 | 4.19 | 4.28 | 4.27 | 4.05 | 4.21 | 4.14 | 3.78 | 3.69 | 3.74 | 3.83 |
| Profit before tax | 0.34 | 8.53 | 1.88 | 8.62 | 11.37 | 9.36 | 11.06 | 8.30 | 8.85 | 10.83 | 27.25 | 3.99 |
| Tax % | 9.0% | 32.1% | 26.7% | 32.3% | 30.5% | 30.6% | 29.7% | 30.6% | 30.2% | 29.2% | 24.9% | 19.0% |
| Net Profit | 0.30 | 5.75 | 1.36 | 5.79 | 7.84 | 6.45 | 7.73 | 5.73 | 6.14 | 7.61 | 20.33 | 3.22 |
| EPS (Rs) | 0.11 | 2.30 | 0.54 | 2.32 | 3.15 | 2.58 | 3.10 | 2.30 | 2.46 | 3.06 | 8.17 | 1.29 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 175 | 178 | 228 | 188 | 200 | 327 | 388 | 329 | 432 | 583 | 856 |
| Expenses | 146 | 156 | 175 | 160 | 166 | 287 | 352 | 293 | 375 | 520 | 779 |
| Operating Profit | 29.92 | 22.92 | 53.83 | 27.94 | 34.91 | 40.91 | 35.90 | 35.90 | 56.80 | 62.86 | 77.76 |
| OPM % | 17.0% | 13.0% | 23.9% | 14.9% | 18.0% | 11.9% | 9.0% | 11.0% | 12.9% | 10.9% | 9.1% |
| Other Income | 0.99 | 0.99 | 0.99 | 5.99 | 7.98 | 5.99 | 2.99 | 9.98 | 0.99 | 0.99 | 0.82 |
| Interest | 5.02 | 4.01 | 3.01 | 2.01 | 2.01 | 5.02 | 11.04 | 14.06 | 10.03 | 10.03 | 13.04 |
| Depreciation | 4.02 | 4.02 | 5.02 | 6.02 | 7.03 | 8.03 | 18.07 | 16.08 | 17.06 | 16.06 | 15.04 |
| Profit before tax | 21.05 | 16.04 | 47.08 | 26.07 | 34.06 | 34.05 | 11.03 | 17.03 | 31.08 | 39.06 | 50.92 |
| Tax % | 20.9% | 20.9% | 2.0% | −22.1% | 4.0% | 37.9% | 34.9% | 32.9% | 30.9% | 29.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.77 | 5.68 | −0.20 | 0.05 | — |
| Net Profit | 16.93 | 11.95 | 45.78 | 30.86 | 32.85 | 20.92 | 6.97 | 11.95 | 21.92 | 26.87 | 37.30 |
| EPS (Rs) | 7.79 | 4.92 | 18.48 | 12.59 | 13.05 | 8.55 | 2.77 | 4.64 | 8.62 | 10.95 | 14.98 |
| Dividend payout % | 0.0% | 10.0% | 8.0% | 0.0% | 15.0% | 6.0% | 0.0% | 22.1% | 29.0% | 23.1% | — |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24.99 | 25.01 | 24.95 | 25.00 | 24.99 | 25.05 | 25.03 | 24.94 | 24.98 | 24.99 |
| Reserves | 34.91 | 47.86 | 90.66 | 120 | 148 | 169 | 173 | 184 | 202 | 222 |
| Borrowings | 29.88 | 24.90 | 21.91 | 24.91 | 34.87 | 92.72 | 101 | 87.67 | 71.72 | 110 |
| Other Liabilities | 58.72 | 58.72 | 50.76 | 41.80 | 54.74 | 96.54 | 102 | 79.61 | 80.62 | 86.58 |
| Total Liabilities | 149 | 156 | 187 | 211 | 263 | 383 | 400 | 376 | 379 | 444 |
| Fixed Assets | 82.69 | 87.71 | 98.62 | 102 | 108 | 173 | 229 | 237 | 233 | 219 |
| CWIP | 3.01 | 2.99 | 1.01 | 9.01 | 38.01 | 63.09 | 11.01 | 6.01 | 0.00 | 5.01 |
| Investments | 1.99 | 3.99 | 2.99 | 2.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 |
| Other Assets | 60.81 | 62.80 | 85.66 | 98.63 | 117 | 146 | 159 | 132 | 145 | 219 |
| Inventories | 16.98 | 20.96 | 24.96 | 27.95 | 36.93 | 41.93 | 52.88 | 43.89 | 42.95 | 91.82 |
| Trade receivables | 21.03 | 22.02 | 30.07 | 25.05 | 32.05 | 50.12 | 52.05 | 46.05 | 74.10 | 96.23 |
| Cash & equivalents | 5.01 | 5.01 | 5.01 | 9.01 | 5.01 | 3.01 | 2.01 | 4.01 | 6.01 | 4.01 |
| Total Assets | 149 | 156 | 187 | 211 | 263 | 383 | 400 | 376 | 379 | 444 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 29.10 | 18.07 | 21.06 | 27.06 | 32.08 | 51.14 | 30.10 | 38.14 | 38.08 | −18.06 |
| Cash from investing activity | −7.99 | −8.99 | −13.01 | −16.99 | −39.98 | −97.92 | −21.01 | −9.99 | −6.99 | −6.99 |
| Cash from financing activity | −18.92 | −8.97 | −7.97 | −5.98 | 2.99 | 44.87 | −9.96 | −26.92 | −29.89 | 21.94 |
| Net cash flow | 1.99 | 0.00 | 0.00 | 3.99 | −3.99 | −1.99 | −0.99 | 0.99 | 1.99 | −1.99 |
| Capex | 7.12 | 8.51 | 13.79 | 16.95 | 47.33 | 98.68 | 21.90 | 18.95 | 7.02 | 6.00 |
| Free cash flow | 22.03 | 10.01 | 7.01 | 10.02 | −10.02 | −47.05 | 8.01 | 19.04 | 31.07 | −24.05 |
| CFO / OP % | 115.1% | 94.1% | 57.0% | 117.1% | 101.1% | 143.0% | 92.1% | 111.1% | 76.0% | −17.9% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 44 | 44 | 47 | 47 | 58 | 55 | 48 | 50 | 62 | 59 |
| Inventory days | 60 | 73 | 80 | 113 | 151 | 79 | 78 | 81 | 58 | 82 |
| Days payable | 130 | 115 | 79 | 68 | 118 | 131 | 121 | 119 | 84 | 60 |
| Cash conversion cycle | −25 | 4 | 49 | 93 | 92 | 3 | 6 | 13 | 37 | 83 |
| Working capital days | −38 | −7 | 41 | 79 | 31 | −6 | 1 | 4 | 15 | 33 |
| ROCE % | — | 21.0% | 42.9% | 18.0% | 19.0% | 14.9% | 7.0% | 8.0% | 14.0% | 15.0% |
For the Sep 2026 quarter, DMCC SPECIALITY CHEMICALS reported sales of ₹274 Cr, up 116.8% year on year and net profit of ₹3.22 Cr, down 43.8% year on year. The operating margin was 4.2%.
DMCC SPECIALITY CHEMICALS' sales for the year to Mar 2026 were ₹583 Cr; over the last twelve months they were ₹856 Cr.
Net profit for the year to Mar 2026 was ₹26.87 Cr, and ₹37.30 Cr over the last twelve months. Earnings per share over the same trailing period were ₹14.98.
DMCC SPECIALITY CHEMICALS reported borrowings of ₹110 Cr at Mar 2026, against cash and equivalents of ₹4.01 Cr.
Cash from operations was −₹18.06 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹24.05 Cr.